Abstract:Xiaoxue Liu, 1 Jiawei Gao, 2 Liuxin Yang, 2 Xingxing Yuan 2, 3 1 Department of Paediatrics, Harbin Hospital of Traditional Chinese Medicine, Harbin, 150010, People's Republic of China; 2 Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China; 3 Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, 150006, People's Republic of China Correspondence: Xingxing Yuan, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China, Email Asthma is a chronic inflammatory disorder of the airways, characterized by a complex interplay of genetic, environmental, and immunological factors that contribute to its onset and progression. Recent advances in researches have illuminated the critical role of exosomal microRNAs (miRNAs) in the pathogenesis and development of asthma. Exosomes are nano-sized extracellular vesicles that facilitate intercellular communication by transporting a variety of bioactive molecules, including miRNAs, and play a crucial role in regulating gene expression and immune responses, which are central to the inflammatory processes underlying asthma. Exosomal miRNAs are emerging as key players in asthma due to their involvement in various aspects of the disease, including the regulation of inflammation, airway hyperresponsiveness, and remodeling. Their ability to influence the behavior of target cells and tissues makes them valuable both as diagnostic biomarkers and as potential therapeutic targets. This review aims to provide a comprehensive overview of the biogenesis of exosomes, the functional roles of exosomal miRNAs in asthma, and their clinical potential. It will explore the mechanisms by which these miRNAs contribute to asthma pathophysiology, discuss their utility in diagnosing and monitoring the disease, and highlight ongoing research efforts to harness their therapeutic potential. Keywords: asthma, exosome, miRNA, biomarker, therapy Asthma is a prevalent chronic respiratory disease that affects over 300 million individuals worldwide. It is characterized by episodic airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation of the airways. 1,2 Symptoms include wheezing, shortness of breath, chest tightness, and coughing, which can vary in intensity and frequency. 3 Despite advances in understanding the pathophysiology of asthma and the development of new therapeutic strategies, there remain significant gaps in effective disease management, especially for patients with severe asthma. 4 Asthma is a heterogeneous disease with various phenotypes, driven by complex interactions between genetic predisposition and environmental factors. 5,6 This complexity necessitates the need for personalized approaches to diagnosis and treatment. Recent studies have increasingly focused on the role of extracellular vesicles (EVs) in asthma, particularly exosomes, which are small, nano-sized vesicles (30–150 nm in diameter) that originate from the endosomal compartment of cells. 7,8 They are released into the extracellular environments when multivesicular bodies fuse with the plasma membrane, and carry a cargo of proteins, lipids, and nucleic acids, including microRNAs (miRNAs), which are short non-coding RNA molecules that regulate gene expression at the post-transcriptional level. 9,10 MiRNAs are involved in various biological processes, including development, differentiation, proliferation, and apoptosis. 11 Dysregulation of miRNAs has been implicated in a range of diseases, including cancer, cardiovascular diseases, and inflammatory conditions such as asthma. 12 In asthma, exosomal miRNAs have emerged as key regulators of immune responses and airway remodeling. They facilitate communication between different cell types within the airway microenvironment, including epithelial cells, immune cells, and fibroblasts, which are crucial for the initiation and propagation of inflammatory responses and for maintaining tissue homeostasis. 13–15 For instance, exosomal miRNAs have been shown to influence the differentiation and activation of various immune cell subsets, such as T lymphocytes, B cells, and macrophages, thereby shaping the immune landscape of this disease. 16–18 Given their stability in biological fluids and their ability to reflect the physiological state of parent cells, exosomal miRNAs hold great promise as non-invasive biomarkers for asthma. 19 Thus, profiling exosomal miRNAs could improve early diagnosis, monitor disease activity, and predict treatment responses, thereby enabling more precise and personalized management of asthma. Compared to other relevant review papers,<sup -Abstract Truncated-

Cardiac and renal complications of carfilzomib in patients with multiple myeloma.

Small Extracellular Vesicle Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma

Exosomes in Allergic Airway Diseases

Mitochondrial Transfer between Airway Cells: Helping the Neighbors, or Sending Them Trash?

The emerging role of extracellular vesicles as communicators between adipose tissue and pathologic lungs with a special focus on asthma

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease

Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation

The role of mitochondria in eosinophil function: implications for severe asthma pathogenesis

A cellular census of human lungs identifies novel cell states in health and in asthma

Multifaceted roles of mitochondria in asthma

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

Airway epithelial-derived exosomes induce acute asthma exacerbation after respiratory syncytial virus infection

Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma

Roles of Exosomal miRNAs in Asthma: Mechanisms and Applications

From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy

Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Th2 cell extracellular vesicles promote eosinophil survival through the cytokine cargo IL-3 and prolong airway eosinophilia.

Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma

Neutrophil Extracellular Vesicles and Airway Smooth Muscle Proliferation in the Natural Model of Severe Asthma in Horses

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma